Endovascular stenting for the management of port-a-cath associated superior vena cava syndrome.
Port-a-cath systems are often essential for the administration of long-term chemotherapy in the treatment of malignancies because they improve venous access, but they are associated with complications, mainly thrombosis of central veins. In the present report, we describe a case of right subclavian and superior vena cava port-a-cath-related thrombosis causing superior vena cava syndrome (SVCS) in a patient affected by Hodgkin's disease. The patient underwent percutaneous revascularization with stent positioning, experiencing immediate relief of symptoms. Endovascular procedures for the treatment of nonmalignant SVCS seem to represent a challenging therapeutic option.
Kostopoulou
Vasiliki
V
Department of Clinical Therapeutics, Alexandra Hospital, Athens Medical School, 80, Vas. Sofias Ave., 115 28, Athens, Greece. vaskos12@otenet.gr
Tsiatas
Marinos L
ML
Kelekis
Dimitrios A
DA
Dimopoulos
Meletios-Athanasios
MA
Papadimitriou
Christos A
CA
D002408:Catheters, Indwelling / Q000009:adverse effects*; D005260:Female; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D008875:Middle Aged; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000150:complications* / Q000000981:diagnostic imaging / Q000628:therapy; D013927:Thrombosis / Q000209:etiology / Q000628:therapy*; D014057:Tomography, X-Ray Computed